Community cohort study examines symptomatic human metapneumovirus infection incidence

A community-based cohort study was conducted in Oregon and Washington to investigate the average incidence of symptomatic human metapneumovirus infection. The specific intervention or exposure, comparator, sample size, and duration of follow-up were not reported in the available data.

The primary outcome was the average incidence of symptomatic human metapneumovirus infection. The study did not report the resulting incidence rate, effect size, absolute numbers, or statistical measures such as p-values or confidence intervals. No secondary outcomes were specified.

No data on safety, adverse events, serious adverse events, discontinuations, or tolerability were provided. The study's limitations and information regarding funding or potential conflicts of interest were also not reported. The practice relevance of these findings cannot be determined without the complete results and methodological details.